Skip to main content
Best News Website or Mobile Service
 
WAN-IFRA Digital Media Awards Worldwide
Best News Website or Mobile Service
 
Digital Media Awards Worldwide
Hamburger Menu

Advertisement

Advertisement

Asia

South Korea agrees to buy additional Pfizer COVID-19 pills

South Korea agrees to buy additional Pfizer COVID-19 pills

Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Freiburg, Germany, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

SEOUL: South Korea signed an agreement to buy additional courses of Pfizer's antiviral COVID-19 pill Paxlovid to cover 400,000 people, the Korea Disease Control and Prevention Agency (KDCA) said on Wednesday (Jan 5).

This brings South Korea's total agreed purchases of oral treatments for COVID-19 to treatments from Pfizer for 762,000 people and treatments from Merck for 242,000 people, the KDCA said in a statement.

Pfizer's Paxlovid is expected to be available in the country from mid-January as scheduled, KDCA said.

The South Korean government reinstated distancing curbs in mid-December as record-breaking daily tallies and serious cases strained the medical system.

BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/ga

Advertisement

Also worth reading

Advertisement